Irish firm’s cutting-edge pet drugs have potential for human use | Business Post

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Waterford-based TriviumVet is raising more than €5 million in the next month to launch new treatments for cats and dogs, which have the potential to also treat people, donalmacnamee97 reports.

Louise Grubb chief executive of Trivium Vet: ‘The actual disease of HCM in cats is a model of what it’s like in humans, for which there isn’t a very effective treatment.’ Picture: Colin Shanahan

The company was founded in 2015 by Louise Grubb, who previously founded pharma storage company Q1 Scientific, as well as Tom Brennan, whose EirGen Pharma was bought by Opko Health in 2015 for around €120 million. “The actual disease of HCM in cats is a model of what it’s like in humans, for which there isn’t a very effective treatment,” Grubb said.

“We’ve . . . really valuable research done in dogs and cats, and we think we can use that to help in the human sphere,” Grubb said.TriviumVet, which has backing from Enterprise Ireland and employs 12 people, did not initially intend to move into the sphere of human healthcare, Grubb said. The original plan – which still stands today, and is developing all the time – was to examine diseases in cats and dogs for which there was no effective treatment, and to plug that gap.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 8. in KR
 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Subsidised companies and dividends, consumer sentiment falls, and crypto oversightSubsidised companies and dividends, consumer sentiment falls, and crypto oversight via IrishTimesBiz
출처: IrishTimesBiz - 🏆 6. / 77 더 많은 것을 읽으십시오 »